 |
|
|
|
December 2000 Cover
|
|
The United Kingdom's Medicines Control Agency has approved an AIDS vaccine candidate for human testing, according to the International AIDS Vaccine Initiative. The modified vaccinia Ankara-strain vaccine is the second part to the vaccination strategy created
in Oxford, England. The first component, a DNA vaccine, has entered Phase I trials in England, and will then be tested in Nairobi, Kenya. The vaccines were created by teams from Oxford University and the University of Nairobi, led by Andrew McMichael and
J.J. Bwayo, based on testing of sex workers in Kenya, some of whom resisted infection for several years.
Editor's Note: from Reuters Health Info Services
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
